Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Epic Sciences and Biosplice Therapeutics Announce Partnership for Metastatic Cancer Trials
Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for […]
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
HaemaLogiX Ltd (HaemaLogiX), the clinical-stage biotechnology company developing novel monoclonal antibody therapies for multiple myeloma, […]
Samsung Biologics Reaches Agreement with Biogen to Acquire Full Ownership of Samsung Bioepis
Samsung Biologics (KRX: 207940.KS) announced today that it has reached an agreement with Biogen for the buyout […]
CONDOR Project for Precision Medicine and Sarcoma Immunotherapy Awarded Close to €10M in the Fifth Call for Hospital-University Research in Health (RHU) Projects
The CONDOR consortium, led by Pr. Antoine Italiano of the Bergonié Institute (Bordeaux, France) is […]
Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]
SBRI Healthcare Awards £1 Million to Pioneering Innovations to Support the Delivery of a Net Zero NHS
SBRI Healthcare has awarded a total of £1 million to ten pioneering MedTech and Digital […]
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments
Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today […]
Spartha Medical Receives €2.4M in Financing from European Innovation Council
Spartha Medical, a French medtech company specialized in developing multifunctional antimicrobial, antiviral and anti-inflammatory coatings, […]
H.E.L Group Appoints Rajeev Kumria as General Manager of H.E.L India
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, […]
Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy
Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more